Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
The study1, the largest in the world to date, investigated anonymised veterinary clinical records of a random sample of almost 4,000 hamsters.
The three most common hamster species were Syrian (golden) hamster (73.5%), Djungarian (winter white dwarf) hamster (13.8%) and Roborovski hamster (6.4%).
From a list of the 20 most common disorders across all hamster species, the most common disorders were "wet tail" – (diarrhoea or liquid discharge) (7.33%), bite injuries from other hamsters (5.88%), overgrown nails (4.13%), overgrown front teeth (3.98%) and traumatic injury (3.80%).
The average age at death across all hamsters was 21 months (1.75 years).
The RVC says a better awareness of the average lifespan of pet hamsters should help veterinary surgeons build realistic expectations for hamster owners and may also help owners accept the animal welfare benefit for euthanasia.
It is also helpful to help children understand the typical natural lifecycle of pet hamsters.
Other findings included:
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC and lead author of the paper, said: “Hamsters can make good pets for both adults and children but until now, very little was published about their health.
"Parents can now help their children with realistic expectations of how long their hamster may live and what are the most common conditions to look out for to protect the health of these delightful little creatures.”
The RVC has an advice sheet on hamster care here: https://rvc.uk.com/hamster-care.
Reference
Firstly, pets that haven’t received primary vaccinations due to the coronavirus outbreak and develop an issue that would have been prevented by a vaccination they were unable to access, will now have that condition covered under their Agria policy.
Secondly, the company has now made it possible for owners of cats and dogs under the age of five to set up a 'Four Weeks Free' policy - which would ordinarily be set up in practice - themselves.
Simon Wheeler, Managing Director of Agria Pet Insurance (pictured right), said: "We have introduced these additional products during the pandemic to ensure that pets remain covered despite new and significant challenges faced by vets and owners. We hope that they alleviate a little of the pressure faced by veterinary staff and worry felt by owners."
Robin Hargreaves, who is Agria's Vet Lead and helped develop the solutions said: "Times are pretty tough in practice right now, and operating on a restricted basis isn’t ideal for us or the pets registered with us. One thing that would make life even harder would be if the percentage of uninsured pets was to rise.
"With Agria making it possible for owners to activate their own 4 Weeks Free policies at this time, even owners that can’t see vets as usual can still protect their pets with insurance.
“Relaxing restrictions around cover for unvaccinated pets will come as a huge relief in some cases, enabling any pets that have missed primary vaccinations or gone past their booster date due to current restrictions to still be insured."
For more information, visit: agriapet.co.uk/guide
The programme includes a mix of online and in-person sessions hosted by Blaise's multi-disciplinary team.
Lara Dempsey, head of soft tissue surgery at the hospital, will start with ‘To close or not to close, that is the question’ on Monday 27th January.
Lara's online session will cover tips and tricks for open wound management and wound closure options, case studies and her preferred products to use in practice.
On Thursday 8th May, head of anaesthesia and analgesia Jacques Ferreira (pictured) will host a one-day workshop on pain management, taking place at Blaise.
Attendees will develop their understanding of acute and chronic pain, and the difference between them.
Jacques will also discuss the future of nerve blocks and share techniques that can be used in practice.
Julie Davis, hospital director at Blaise, said: “We have an incredible team here at Blaise and are very much looking forward to sharing our collective knowledge with colleagues from across the veterinary profession.
The full programme of free CPD events:
www.blaise-referrals.com/vet-hub/cpd-events
The ISFM says Congress will offer veterinary professionals an extensive scientific programme designed to support a multi-modal and cat friendly approach to caring for feline patients with acute upper urinary tract disease and other emergencies.
Speakers will include Søren Boysen (Emergency & Critical Care), Serge Chalhoub (Internal Medicine), Laura Owen (Soft Tissue Surgery) and special guest Allyson Berent (Non-Invasive Surgery).
Sam Taylor MRCVS, ISFM Veterinary Specialist Lead (pictured right) said: "We seem to be seeing more and more feline urinary cases, urolithiasis and acute kidney injury - and of course the familiar blocked cats!
"In Dublin, I can’t wait to hear how to approach these cases as well as look more in-depth at ECC and discuss cat friendly critical care amongst many other topics from all angles – surgery, medicine, behaviour, imaging and more!’
The 2023 ISFM Feline Congress Dublin is open to veterinary surgeons and nurses of all experience levels.
https://icatcare.org/congress-2023-dublin/
Ms Gurrin faced two charges, the first being that she had issued prescriptions for Roaccutane tables, indicating they were for the treatment of an animal when they were in fact for a human.
The second charge was that Dr Gurrin’s conduct in relation to the first charge was dishonest and/or misleading, and took place in circumstances where Dr Gurrin was not professionally qualified to write a prescription for a human.
Ms Gurrin admitted the allegation in its entirety and the Committee therefore found it proved.
The College submitted that Dr Gurrin breached fundamental tenets of the Code of Professional Conduct and acted dishonestly and, as such, that the admitted facts amounted to disgraceful conduct.
The Committee accepted that Dr Gurrin’s conduct involved dishonesty, but took into account the context: that Dr Gurrin was seeking to help in continuing a course of medication that she understood to have been properly prescribed by a specialist physician.
Mitigating factors included the lack of artifice or sophistication in the drawing of the prescription and its presentation to the pharmacist, in that Ms Gurrin didn't invent an animal name or species, or any kind of elaboration or backstory when challenged by the pharmacist on the prescription.
In addition, there was no financial or other personal gain, it was a single isolated incident, it was a spur of the moment decision without reflection, no harm was caused or risked to any animal, Ms Gurrin had a long and previously unblemished career and lastly she showed insight into the offence.
The committee also took into account the character testimonials which showed Ms Gurrin not only to be an exceptional vet, but a dedicated professional who had nurtured a very strong team, and someone who is held in extraordinarily high regard by both her clients and colleagues.
There were no aggravating factors.
The Committee considered that the case was too serious to take no further action, but that there was no ongoing danger to the public or risk to animal health.
Kathryn Peaty, chairing the Committee and speaking on its behalf, said: “The Committee has reached the conclusion that it is appropriate to impose a reprimand and a warning in this case.
"It would serve no purpose to impose a more severe sanction of a suspension and deprive Dr Gurrin’s clients of her valuable service and to deprive Dr Gurrin of the opportunity to practise for however short a time.
"The Committee considered that it is right to recognise that this misconduct was an aberration in a fine career, which is not characteristic of this veterinary surgeon and which happened when she was off her guard and in circumstances when she was mistakenly trying to help another in what she thought was a safe way.
“The Committee therefore decided, in the particular circumstance of this case, to impose a reprimand and warning on the basis that it would be proportionate in order to maintain public confidence in the profession and declare and uphold proper standards of conduct and behaviour.”
The initiative is called Project NURSE, which stands for Nurturing and Using REVN Skills and Experience.
The first stage of Project NURSE is to survey horse owners to find out what they understand about the role of REVNs and if they would be receptive to nurses visiting yards to carry out certain procedures, under the direction of a vet and within the scope of what is permissible by the RCVS.
Phillippa Pritchard (pictured right), an equine veterinary nurse and training manager at Liphook Equine Hospital, one of VetPartners’ practices, has been awarded a £1,000 grant by MSD Animal Health to promote the survey and is helping lead Project NURSE on behalf of VetPartners.
Phillippa said: “REVNs have an important role to play in equine practices and hospitals, but many nurses would welcome the opportunity to be more involved in yard visits and put their skills to the best possible use.
“There are many procedures we are qualified to do, including changing wound dressings, taking blood samples and administering prescribed doses of sedation, and by making more use of these skills we feel we would be able to help our practices provide an even better service to patients and clients.
“I also believe that having more interaction with owners and their horses would have a positive impact on job retention because equine nurses would be more fulfilled in their role and feel they have opportunities to develop their careers.”
VetPartners equine director Julian Rishworth added: “Our central ethos revolves around practices being a great place to work and striving for clinical excellence. Equine veterinary nurses are such an integral part of practice teams and if we don’t allow them to fully use their skills and fulfil their potential we are failing the team, our clients, their horses and our own group aspirations.”
It's believed that VetNurse.co.uk and VetSurgeon.org, which run on a platform that predates Facebook, may be the first online communities to require good manners.
Under the new policy, anyone who posts anything in the forums which is sarcastic, belittling, snide, rude or unkind towards another member will face immediate removal from the website.
This marks a very radical change to the previous policy in which members were free to say pretty much what they wanted.
VetNurse.co.uk Publisher Arlo Guthrie said: "For years, I felt the right to free speech trumped all, and would rarely intervene.
"When I did, the worst anyone faced was a temporary suspension.
"As time has passed, I've realised the limitations of the written word, especially the short-form, hastily-written word, which can cause real distress.
"We all moderate our language offline, it's just a question of realising that we need a different set of standards online, to account for the lack of facial expression and immediacy of reply, and the public nature of the discussion.
Some people have questioned the new policy, and whether it will stifle proper debate.
Arlo added: "I believe not. It is perfectly possible and OK to disagree with someone, and express that disagreement forcefully, without being sarcastic.
"On the contrary, I think that allowing bad manners has a far more chilling effect on free speech, because it scares off opinions from the majority of more moderate members"
Others have asked whether this new policy is the consequence of the new partnership with Improve International, or proposed new laws surrounding social media.
Arlo said: "Again, no. It was a very personal decision I reached after years of wrestling with the problem. It was precipitated by a series of unkind posts and I just thought 'enough's enough'.
"That said, I am really excited about the prospect of working with Improve to grow the community as somewhere its members can come for high quality clinical content and authoritative opinion, which for sure would be hard to achieve if we don't have a friendly, collaborative atmosphere."
Another issue raised about zero tolerance is whether it is fair that there may be no second chance.
Arlo said: "I've tried loads of things over the years. Warnings. Red cards. Suspensions. None of them work. People just push the boundaries.
"But the moment I said 'zero tolerance', it seems people get the message and moderate themselves accordingly."
"I'm delighted. I want people to think of VetNurse.co.uk as somewhere everyone can come for authoritative advice and support, confident of a friendly welcome and the highest standards of online behaviour."
Mary (or, to give her her full title, Dr Mary Fraser BVMS PhD CertVD PGCHE FHEA MAcadMEd CBiol FRSB FRSPH FRCVS) focussed on decision-making in practice while studying for her MRes in Clinical Veterinary Research, looking at how vets and owners influence the decision making process. This led her to consider how decision making is taught to students.
As part of the initiative, Mary has launched a new website: www.clinicaldecisions.org, which, together with a supporting blog, is designed to help nurses, students and recent graduates examine their decision making in practice, consider how owners influence it, and take forward shared decision making for the benefit of all.
Mary said: "As a student decision making can seem difficult. Working with owners, all of whom have different expectations, can add to those challenges.
"I hope that by bringing that discussion to the fore we can support each other and allow future vets and veterinary nurses to identify their own strengths in supporting owners to make the best decisions for their animals."
Find out more and contribute to the discussion at www.clinicaldecisions.org
The full eligibility criteria, including FAQs and guidance notes, for veterinary nurses who wish to stand for VN Council can be found at: www.rcvs.org.uk/vncouncil21. The deadline for nominations is 5pm on Sunday 31 January 2021.
Due to the ongoing postal problems caused by the coronavirus pandemic, RCVS Council has approved a temporary change to the RCVS Election Scheme this year to allow nominations to be submitted electronically, rather than in hard copy. This temporary change is currently before the Privy Council for final approval.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the elections, said: "For prospective RCVS and VN Councils election candidates this will mean that, rather than having to send us hard copies of your nomination documents in the post, these can simply be emailed to the College along with the relevant digital photographs and electronic signatures."
The College has also updated its information and guidance for prospective candidates, including an informal ‘job description’, to help them better understand what it means to be members of VN Council, their responsibilities, commitments and how they help the College meet its strategic goals, as well as the principles and rules governing their conduct.
Prospective candidates for VN Council can contact Matthew Rendle, VN Council Chair, for an informal conversation on what it means to be a Council member on vncchair@rcvs.org.uk.
Matthew said: “I was very proud to recently be appointed as Chair of VN Council with responsibility for overseeing it and its role in important decision-making on some of the big issues for veterinary nursing around training and education, post-registration qualifications and registration.
“Over the past years, the role, responsibility and stature of VN Council has really grown. Its members have been at the forefront of important projects such as VN Futures, which is helping the profession identify and plan for its future, and have been ambassadors for the profession at events such as our recent VN Evening.
“Last year we had a record number of veterinary nurses standing for election to VN Council, a fantastic development that I hope will be repeated this year as you really can make a difference on VN Council and play a role in speaking up for and promoting our profession. Please do get in touch with me if you wish to find out more.”
There is one more RCVS Council meeting before the nomination period ends. It will take place online on Thursday 21st January 2021 and prospective candidates who would like to get a feel for it are welcome to attend as observers: contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk.
The coils need to be cooled to -460 °F in order to get good quality images.
To achieve the same result without helium, Hallmarq’s new MRI uses a conduction-based cooling system in a strong vacuum, which eliminates the need for helium, a quench pipe, oxygen monitor, or any additional power.
This, Hallmarq says, makes the new system more environmentally friendly than its helium-based counterparts and reduces the upfront and ongoing costs of offering a veterinary MRI service to patients.
The new technology comes in response to growing concerns over helium supply.
Extraction and usage of helium is quickly outpacing its natural synthesis, as a result of which, Hallmarq says helium prices have soared from £12.75 per litre in December of 2017 to between £50 and £55 per litre in June 2022.
For veterinary hospitals already using high-field MRI machines, or for those considering them in the future, reliance on the 1,500-2,200 litres of helium required to keep a standard MRI functioning may not be sustainable.
Hallmarq’s Chief Technology Officer Dr. Steve Roberts said: “Hallmarq’s Zero-Helium Small Animal 1.5T MRI system increases access to diagnostic care for small animal patients, while lessening the financial, environmental and supply chain risks associated with traditional helium-based MRI systems."
www.hallmarq.net.
Bethany said: “I have always wanted to provide the best care for my patients and support my team in their work too.
This qualification was the next step in that and thinking of my patients and peers was really the inspiration for me.
“At work I received invaluable help to get my VTS and was able to access Linnaeus’ enhanced support package for my studying.
"It included mentors and help from nurses in the central support team along with study time, extra CPD allowances and networking.
“It was great to work alongside others aiming for the same thing, and to have the support from my employer.”
She added: “Having a better understanding of anaesthesia allowed me to better support patients through procedures and nurse them.”
The qualification took around two years to complete, with hours of training, work and exams.
Bethany added: “To even begin the application process, you must have worked in the discipline for five years, have 40 hours of CPD in the speciality and had two letters of recommendation from a specialist.
“The qualification is two years, with a casebook to complete, four case reports and two exams.
"It’s been hard work but it’s definitely worth it.”
The company says Locox TT has been developed to have high levels of EPA and DHA Omega-3, with independent lab analysis showing it contains over four times more Omega-3s than the market leading supplement.
The new product also chondroprotective ingredients and antioxidants.
Locox TT comes in tablet form: 1-2 tabs per day, with no loading phase required.
Will Peel, TVM UK’s product manager said: "Locox TT has undergone extensive independent testing so vets can be assured that the information they give to pet owners is verified and can be trusted.
"With an abundance of joint supplements on the market, we believe it is important that vets are able to make informed decisions when selecting their chosen brand, by providing clear, trustworthy information, alongside a high-quality product.’
TVM says it will be making client leaflets and waiting room questionnaires to help pet owners identify the symptoms of osteoarthritis in dogs.
For more information, visit www.tvm-uk.com/locoxtt or contact your local TVM territory manager.
Expanding on the training available in autumn 2022, which was launched based on the results of an extensive training pilot, MMI is offering a total of 14 sessions taking place both online and in person over the next few months. Sessions will be running from January to April 2023. The courses will cover areas that have been identified as priority topics from previous MMI surveys, feedback from the professions, and evaluation of the training pilots.
Mind Matters Initiative Manager, Lisa Quigley, said: “Mental health and wellbeing are impacted by a whole host of structural and societal factors and maintaining a healthy workforce goes far beyond supporting people on an individual level.
"Whilst it is undoubtedly important to provide people with the skills they need to look after themselves, we are aiming to expand on this by providing individuals with the skills and knowledge needed to recognise and address wider collective issues. For example, the importance of creating and maintaining a positive workplace culture.
Session dates and specific topics are as follows:
Mental Health First Aid (£30 in-person)
9am – 5pm
Psychological Safety and Civility (£20 in-person, £15 online)
In-person – 9am – 4pm
Online – 9am – 1pm
Sustaining Your Emotional Health (£15 in-person)
2pm – 5pm
For more information on the training courses, visit: https://vetmindmatters.org/training/
This year, there have been over 30,000 nominations for the awards.
The finalists this year are:
Vet Nurse of the YearCaroline Jones, Battle Flatts Veterinary Surgery, YorkHelen Rooney, Pet Blood Bank, LoughboroughLesley Ramsey (pictured right), Debenham Veterinary Practice, Stowmarket
Vet of the YearAndrew Hayes, Towcester Equine Vets, TowcesterClare McCabe (pictured right), Claymill Veterinary Clinic, CookstownLaurence Behrens, Goddard Veterinary Group, Dagenham
Practice Support Staff of the YearRhiannon Lewis, Streatham Hill Vets, StreathamLaura Cameron, Lomond Veterinary Clinic, HelensburghLouise O’ Reilly, Vets4Pets, Llanrumney
Practice Manager of the YearKristen Lorimer, Blue House Veterinary Centre, Stoke-on-TrentLouise Newman, Blue Cross Vets, MertonNicki Ridgeway, Vets4Pets, Ridgeway
Practice of the YearHollybank Veterinary Centre, NorthwichLanes Vets, PoultonMilfeddygon Williams Vets, Gwynedd
The awards will be hosted at the Kimpton Clocktower Hotel, Manchester on 23rd March.
Bella von Mesterhazey, Sales & Marketing Director at Petplan, said: “This year’s finalist line-up includes an outstanding array of veterinary professionals and practices, and Petplan is delighted to be celebrating the highest achievements in pet healthcare once again."
The annual survey gives an overview of remuneration levels within the veterinary sector.
It covers everything from basic earnings, bonuses, dividends and overtime, to benefits such as accommodation, car allowances and pensions.
SPVS is asking everyone in the veterinary profession to take part, whether they're in a clinical or non-clinical role, a vet, a nurse, a practice manager, support staff or working in industry.
The main findings of the survey will be published in a report and freely available to any participant who gives their email address at the end of the survey.
SPVS members will be able to access the full results with additional commentary and analysis.
All survey data is treated as strictly anonymous and totally confidential.
https://www.smartsurvey.co.uk/s/LOZS6O
Any questions: office@spvs.org.uk
Concern has been expressed in the profession about environmental contamination from products used in companion animal treatment for ectoparasites, such as fleas and ticks.
In recent years there has been a widely documented fall in the abundance of many terrestrial invertebrate populations1.
While the decline has been mostly linked to agricultural chemicals, there is a concern that companion animal ectoparasiticides could also be a contributing factor, with a recent study2 confirming the presence of common compounds used in flea-treatment3 in UK waterways.
However, the association with companion animal ectoparasiticides is currently poorly understood, with a significant knowledge gap and little robust research available to assess the true importance and environmental consequences.
The funded project ‘Assessing the Environmental Risk from Ectoparasite Treatments in Companion Animals’ will be led by Professor Richard Wall, Professor of Zoology and Dr Emily Bell, Senior Lecturer at University of Bristol in collaboration with Dr Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, and Lizzie McLennan-Green, Small Animal Veterinary Director at CVS.
It will be conducted via a PhD studentship at the University of Bristol as part of the CVS Clinical Research Awards.
The research will include a longitudinal ‘citizen science’ study with pet owners to develop a greater understanding of owner use and attitudes towards ectoparasiticides.
It will also include laboratory assessments of ectoparasiticide residues collected from companion animals to provide evidence-based information on the potential environmental impact of the treatments when applied to companion animals.
It is hoped the study will help the wider veterinary profession develop the most appropriate approaches to prescribing and use of ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’. The study is also set to benefit companion animals, as the research will inform strategies to ensure the most appropriate control of parasitic burden to pets.
The project starts in January 2023 and will run for three-years as a full time PhD.
CVS is providing £95,000 to fund the research.
References
At a hearing in April Dr Johnston had admitted all the charges against him, which related fraudulent claims for the treatment of animals, two of which were fictitious, where he arranged for the insurance claims to be diverted and paid into a personal bank account.
Dr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
Committee Chair Paul Morris said: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing on earlier this month, the Committee considered what sanction to impose.
The Committee found that aggravating features of his misconduct were that it was premeditated, carefully planned and sophisticated in that it involved the creation of numerous and extensive false clinical records to support his fraudulent claims.
It also considered the fact that he implicated an innocent professional colleague who worked alongside him at the practice, that he abused the trust placed in him by clients, that the dishonest conduct was repeated and that it involved significant financial gain in excess of £13,200 to be further aggravating features of his conduct
In terms of mitigation, the Committee accepted that he had made early admissions regarding his conduct to his employer and the College and accepted responsibility.
The Committee also heard that he had made attempts at remediation involving repayments of some of the sums lost by the practice and insurers.
It also considered positive testimonials from family and professional colleagues and the fact that Dr Johnston had taken significant steps to deal with the gambling addiction that was at the root cause of his misconduct.
Having considered all the evidence, the Committee decided to postpone its decision on sanction for a period of 2 years on the condition that Dr Johnston agree to undertakings including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
Paul added: “In reaching this conclusion the Committee wishes to make it clear that it has taken an exceptional course in this case.
"Ordinarily conduct of the type covered by the charges which this respondent has accepted will merit the imposition of a sanction of removal from the Register or a period of suspension from the Register.
"In this instance the Committee has found it possible to take the course that it has because it is satisfied that the respondent was, at the time, suffering from a recognisable psychiatric compulsive addiction… and that the fraudulent attempts by the respondent to obtain funds with which to gamble would not have occurred but for this psychiatric condition.
“The Committee further considers that the undertakings offered by the respondent will serve to reduce the risk that he will relapse into gambling again, for his conduct will be closely monitored and he will accept continuing support and guidance from the organisations currently assisting him.
“The Committee is also satisfied of the requirements that neither animals nor the public will be put at risk by this proposed course of action; that the respondent has demonstrated insight into the seriousness of his misconduct and that there is currently no significant risk of repeat behaviour; that his practicing standards are not in need of improvement so long as he continues to fulfil his CPD obligations; that the undertakings offered are capable of being met, are appropriate and are measurable; that there is evidence that his underlying medical problem is being appropriately addressed, will be monitored and reported on; and that he has responded positively to the opportunities for support and counselling which have been offered to him.”
If Dr Johnston fails to comply with his undertakings the Committee will reconvene and consider the charges with the full range of sanctions at its disposal.
www.rcvs.org.uk/disciplinary
The study, which was led by the College's VetCompass programme, found that British bulldog ownership has increased from 0.35% of all puppies born in 2009 to 0.60% in 2013.
At the same time, the study found that British bulldogs suffer more than other breeds from a number of conditions associated with their aesthetic characteristics, including: skin fold dermatitis (7.8%), prolapsed gland of the third eyelid or 'cherry eye' (6.8%), interdigital cysts (3.7%), entropion or inward turning of the eyelid (3.6%), and corneal ulceration (3.1%).
Worse still, only 3.5% of the 1,621 British bulldogs analysed in the study were diagnosed with brachycephalic obstructive airway syndrome (BOAS), despite an earlier study reporting that 84.8% of tested Bulldogs are affected by BOAS to some extent, with 44.0% exhibiting clinically relevant disease2.
This, say the researchers, suggests owners consider breathing problems such as snoring as normal and are not therefore taking their dogs for needed check-ups.
12.7% of British bulldogs suffer from ear infections, 8.8% from skin infections and 8.7% from obesity
Males are more likely than females to develop skin infection, interdigital cysts, atopic dermatitis and aggression, whereas females are more likely to develop dental disease and obesity.
The average adult bodyweight for a British bulldog is 26kg.
The average lifespan of bulldogs is 7.2 years.
The most common causes of death are heart disease (11.8%), cancer (10.9%) and brain disorder (9.1%).
The RVC says that the results of the study will support initiatives by the Kennel Club and the UK Bulldog Breed Club to improve breeding and also help owners and vets prioritise tackling the leading issues British bulldogs face.
Dr Dan O’Neill, VetCompass epidemiologist at the RVC and Chairman of the Brachycephalic Working Group, said: "The UK has seen unprecedented increases in the popularity of certain short-faced breeds over the past decade. This has led to a series of well-documented welfare issues relating to how these dogs are bred and sold for the UK pet-owning market, high levels of dumping of unwanted dogs into the UK charities and health problems that are intrinsically linked to the extreme body shape of these dogs.
"This new study gives firm evidence for the first time on the true levels of popularity and also of disease diagnosed in the wider population of bulldogs in the UK. This information can help to move the conversation on welfare from 'what are the issues' to 'how do we deal with these issues'. Reliable evidence is pivotal to good decision-making."
Dr Rowena Packer, BBSRC Research Fellow at RVC, said: "The bulldog is an iconic breed but concerns over the health problems allegedly facing these popular dogs have mounted in the past decade. It is extremely valuable to have solid data on the health problems facing this breed, confirming a number of inherent breed predispositions that need to be tackled.
This data supports current initiatives encouraging breed reform, particularly regarding health problems inherently related to their looks, and the need for selection for healthier body shapes. For example, skin fold dermatitis was common in bulldogs and is associated with the desired wrinkled face in this breed – this calls into question the justification of this and other such breed traits that put dogs at risk of potentially avoidable disease."
Steve Dean, Chairman of the Kennel Club Charitable Trust said: "The Kennel Club has put into place a number of crucial measures over the years to monitor, protect and improve bulldog health and to provide the many responsible breeders with the tools they need to do the same, but this paper highlights there is still work to be done."
The study is published open access in PLOS ONE.
References:
The new guidance will remove the absolute requirement for veterinary surgeons to perform a physical examination before prescribing POM medicines, making it instead a matter for professional judgement.
However, the proposed new guidance also imposes a requirement for veterinary surgeons who do NOT physically examine the animal prior to prescribing to provide a 24/7 follow-up service which includes a physical examination.
Furthermore, the new guidance will state that: "Where the veterinary surgeon is not able to provide this service [the physical exam] themselves, they should arrange for another veterinary service provider to do so. This arrangement should be made before veterinary services are offered and confirmed in writing as part of the conditions of service agreed by the client."
This requirement to provide a physical 24/7 follow-up would appear to safeguard animal welfare and protect against the risk of online-only businesses (in the UK or abroad) with lower overheads cherry-picking the job of prescribing medicines.
It should also protect against veterinary surgeons feeling pressured to prescribe inappropriately, because the new, stricter requirements will make it easier for them to decline to do so.
However, the BVA doesn't agree with the new proposals. It feels that remote prescribing should be delivered under the auspices of a Veterinary Client-Patient-Relationship (VCPR), which, according to the American Veterinary Medical Association, requires a physical examination.
BVA President Malcolm Morley, said: “The changes to ‘under care’ guidance are a watershed moment, so it’s positive to see that they have evolved in response to feedback from the profession. New technology presents exciting opportunities to enhance existing veterinary services and has benefits for practices as well as clients and their animals.
"However, BVA has been very clear that we believe remote prescribing can only be safely delivered where a vet-client-patient relationship has been established.
"This is an internationally recognised concept, and we are disappointed that the RCVS has decided not to embrace it.
“Having voted to implement these changes, it is incumbent upon the RCVS and the profession to scrutinise how they play out.
"At BVA we plan to develop advice and resources to support our members and help them comply with the new guidance and realise any benefits of remote veterinary service provision.’
“It is now vital that a timeframe for a review is quickly put in place, so any negative impacts on animal welfare or the sustainability of veterinary services can be dealt with swiftly.”
Council voted by a majority of 20 to 3 in favour of the changes, which it then decided should come into force between 1st June and 23rd December 2023, subject to a review at the next meeting.
Discuss the propose changes here
Kit, who has served on Council as an elected member since 2013, is currently the Chair of the RCVS Finances & Resources Committee and has been RCVS Treasurer for the past three years.
He is also a member of a range of committees and project groups across the RCVS including: the Audit and Risk Committee; the PIC/ DC Liaison Committee; the Certification Subcommittee; the Estate Strategy Project Board; the RCVS Knowledge Board of Trustees; and the Advanced Practitioners Panel.
Since 2003 Kit has been working as an internist (he is an RCVS-recognised Specialist in Small Animal Medicine) in private referral practice. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
His interests include workforce issues, communicating the diverse clinical and non-clinical skills of veterinary surgeons to the general public and government, and facilitating life-long learning through achievable further professional qualifications and effective CPD.
Kit said: "It was a great honour to be elected as the next Junior Vice President by my fellow council members. I feel that I can make a positive contribution to the work that the RCVS is already undertaking in ensuring the veterinary team remains healthy and respected. In particular I am keen to look at how the RCVS can help find solutions to our workforce issues - improving retention as well as encouraging and facilitating vets and nurses back into the profession."
In addition to Kit being elected as JVP, the current holder of that office, Dr Mandisa Greene, was confirmed as President for 2020-21 and current President, Dr Niall Connell, was confirmed as Senior Vice-President for this period.
Professor Susan Dawson was voted in as RCVS Treasurer, and she will be formally invested in this role at Royal College Day on Friday, 10 July.
Professor David Argyle has been elected as Chair of Advancement of the Professions Committee for a second year, Dr Susan Paterson has been elected as Chair of Education Committee for her second year, and Dr Melissa Donald has been elected Chair of Standards Committee for her second year.
Kit and Melissa's positions are subject to their successful re-election in the 2020 RCVS Council Elections
More information on the RCVS Council and its members can be found on the RCVS website: https://www.rcvs.org.uk/who-we-are/rcvs-council.
The Disciplinary Committee, chaired by Mr Stuart Drummond, considered six charges against Dr Gunn.
The first charge alleged that, early in 2018, Dr Gunn failed to provide appropriate and adequate care to the dog. In particular, having removed a mass from the right thorax, he undertook an excess number of surgical procedures, including under general anaesthetic, within a 13 day period; performed these procedures without offering alternative treatments or discussing referral with the owners; failed to recognise infected wounds; and administered an antibiotic when the dog was infected with MRSA and E-coli.
The second charge alleged that Dr Gunn failed to communicate adequately, openly and honestly with the owners of the terrier on multiple occasions between 16 January and 3 February 2018. This included but was not limited to: failing to provide the owners with an estimation of fees; failing to inform them in advance of the procedures performed; failing to inform them of options for treatment; and failing to inform them that the terrier had an infection when he knew or ought to have known that she did.
The third charge alleged that Dr Gunn failed to obtain informed consent in relation to the further procedures performed on the terrier in charge one.
The fourth charge alleged that Dr Gunn failed to maintain adequate clinical records in relation to the management of the dog, and that he failed to record the prescription and administration of drugs to treat the terrier.
The fifth charge alleged that Dr Gunn indicated to the owners that euthanasia was the most appropriate treatment option and/or that there were no other realistic treatment options, when this was not the case and when he ought to have known this was not the case.
The sixth charge alleged that, during the course of a referral of the terrier to another practice, Dr Gunn failed to provide an adequate history of his management of the dog and that he informed the practice that the owners had no finances when this was not true, amounting to an incomplete account of his dealings with the owners and to a breach of their confidence.
At the outset of the hearing the respondent admitted to a number of the allegations within the main six charges, which were found proved by the Committee.
Of the charges not admitted to, a number were found proved and the Committee then went on to consider whether or not Dr Gunn’s conduct amounted to serious professional misconduct.
In considering the aggravating factors, the Committee took into account that the dog’s suffering was prolonged because of the persistence of Dr Gunn in pursuing a single ineffective treatment approach.
With regards to mitigating factors, the Committee found that Dr Gunn was remorseful as to his actions, that there was no financial motivation on the part of Dr Gunn in respect of his treatment of the terrier, and that there is a low risk of repetition because Dr Gunn has sought to learn from this experience. A number of relevant and high-quality testimonials were also provided by colleagues and many satisfied owners on behalf of Dr Gunn.
Considering both the aggravating and mitigating factors, the Committee was satisfied that Dr Gunn’s conduct fell far below the standard expected of a registered veterinary surgeon for a number of the charges.
The Committee then considered what sanction to impose on Dr Gunn. The Committee was satisfied that the misconduct found proved was in relation to the treatment of one dog only and therefore it was at the lower end of the spectrum. However, the conduct took place over a prolonged period of two weeks which in the Committee’s view required a sanction. In such circumstances, and with the significant mitigation, the Committee decided that the appropriate and proportionate sanction was to reprimand Dr Gunn and to warn him about his future conduct.
Speaking on behalf of the Committee, Mr Stuart Drummond said: "The Committee concluded that the effect of a reprimand alongside the Committee’s findings on disgraceful conduct in a professional respect was a sufficient and proportionate sanction. The Committee found Dr Gunn to have developed sufficient insight into his failings and it was satisfied that the disciplinary process had been a salutary experience and that he is very unlikely to pose a risk to animals in the future or to contravene professional standards.
"The Committee decided that a warning as to future conduct was necessary to reduce the risk of any repetition of any similar conduct for Dr Gunn in the future. It therefore concluded that the sanction of a reprimand and warning would be a sufficient in the circumstances of this case having taking into consideration all the powerful personal mitigation."
The complete list of charges and the Committee’s full facts and findings can be found at www.rcvs.org.uk/disciplinary
The CVS practice aimed to change its prescribing culture by adopting an evidence-based, case-by-case approach and supporting its vets in only using antibiotics where absolutely necessary.
The practice identified the use of antibiotics in the treatment of cat bite abscesses (CBAs) as worthy of investigation.
Cefovecin, a third-generation cephalosporin and critically important antibiotic, is often used in the treatment of CBAs.
The practice first sought guidance from a dermatology specialist with an active research programme involving the study of antimicrobial resistance (AMR).
It then developed a clinical guideline advising that if a cat has a discrete abscess, with no pyrexia (raised temperature) and no cellulitis, antibiotics are not required.
White Lodge then conducted an eight-month clinical audit across its Exmouth Hub, with the aim of measuring the effect of the new guideline.
The practice treated patients with CBA’s with NSAIDS, lancing and flushing (if necessary), and cleaning of the abscess.
Owners were advised to flush the affected area at home once daily.
An antibiotic awareness leaflet was given to clients with an explanation of the reasoning behind not prescribing antibiotics.
Cats presented 5-7 days after treatment for a nurse re-examination.
A consultation template was created for both the vet at initial presentation and another for the nurse’s post treatment check, to gather standardised information.
The measure of successful treatment was whether, on re-examination, the CBA site appeared free from infection and wound healing was evident.
If the wound had not started to heal or if there was infection or pyrexia, the treatment was deemed to have failed and further treatment was provided.
Analysis of the results showed that of the 22 cats included in the audit, 19 (86%) did not need antibiotics to successfully treat the abscess.
There was also a 32.6% reduction in the number of times cefovecin was dispensed in the eight-month period after the audit started, compared with the previous eight months.
Emily Parr, Head Veterinary Surgeon at White Lodge, said: “We think, due to lack of confidence in treatment without antibiotics as well as client pressure or expectation, the profession tends to default to the prescribing of antibiotics.
“However, this clinical audit has given our veterinary colleagues increased confidence in treating CBA’s without antibiotics.
"There has also been an improved client understanding in accepting treatment without antibiotics.
"Clients have also been positive when minimal intervention has been required, particularly as it eliminates the cost of antibiotics.
"This has had a positive impact on the vet-client relationship and trust in our practice.
“Antimicrobial resistance is continuing to threaten the efficacy and treatment of an ever-increasing range of infections.
"So we hope that our CBA clinical audit outcome results will help to set a benchmark and shape clinical guidelines for the wider veterinary profession in this area.”
The trial, which was launched last November, will now continue until May, when Council will decide whether to provide e-certificates to new registrants as a standard practice.
Newly qualified nurses who have been taking part in the trial have been able to download their e-certificate from the RCVS website, although they are also able to request a printed hard copy.
Robert Hewes, RCVS Head of Insight and Engagement, said: “Thank you to all those newly-qualified veterinary nurses who took part in the trial and especially to those who provided their feedback and thoughts on the e-certificate.
“From those that have completed the survey, it is clear that there is still a great deal of pride and meaning attached to having a hard copy certificate which is why we will continue to offer these to all our newly-qualified veterinary nurses.
"However, the feedback from the vet nurses overall regarding the e-certificates were that they appreciated that there was a benefit from an environment and sustainability point of view, as well as the practicalities of having immediate and easy access to their proof-of-registration.”
E-certificates for newly-qualified veterinary surgeons was trialled in early 2021 and rolled out as standard practice to all new veterinary registrants from summer 2021.
Robert added: “We would like to take this opportunity to make clear to prospective employers of both newly-qualified veterinary surgeons and veterinary nurses involved in the trial, that the e-certificates are now a legitimate form of identification of registration and that they no longer require a hard copy.
"However, if they are in any doubt about an individual’s registration status, they shouldn’t hesitate to contact the Registration Team on registration@rcvs.org.uk or 020 7202 0707.”
Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.